Skip to main content

Table 1 Presence or absence of cervical arterial calcification in quartiles based on serum osteoprotegerin, osteocalcin, FGF23, and 25-hydroxyvitamin D3 levels in 124 patients with type 2 diabetes

From: Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes

 

1st quartile

2nd quartile

3rd quartile

4th quartile

Serum osteoprotegerin (pg/ml) a

<5.6

5.6-8.4

8.5-52.7

52.8- 9027

  No calcification, n

26*

25

19

16#

  Calcification, n

5#

6

12

15*

Serum osteocalcin (ng/ml) b

0.77-0.82

0.83-0.92

0.93-1.53

1.60-10.56

  No calcification, n

24

18

21

23

  Calcification, n

7

13

10

8

Serum FGF23 (pg/ml) c

10.0-22.7

22.9-29.0

29.7-40.7

42.0- 148.0

  No calcification, n

24

20

19

23

  Calcification, n

7

11

12

8

Serum 25-hydroxyvitamin D3 (nmol/l) d

29.2-48.1

48.6-77.3

78.6-119.1

121.1-239.3

  No calcification, n

20

19

25

22

  Calcification, n

11

12

6

9

  1. a P=0.015 by chi-square test. *: Number of subjects significantly greater than other quartiles. #: Number of subjects significantly less than other quartiles.
  2. b P=0.278 by chi-square test.
  3. c P=0.499 by chi-square test.
  4. d P=0.364 by chi-square test.